Edaravone Market By End-users ( Clinics, Hospitals ), Industry Trends, Estimation & Forecast, 2017 - 2025
CHAPTER 1. INTRODUCTION
- 1.1. RESEARCH METHODOLOGY
- 1.1.1. ERC desk research
- 1.1.2. ERC data synthesis
- 1.1.3. Data validation and market feedback
- 1.1.4. ERC data sources
CHAPTER 2. EDARAVONE MARKET OVERVIEW
- 2.1. EDARAVONE MARKET INTRODUCTION
- 2.2. GLOBAL EDARAVONE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
- 2.2.1. Global Edaravone Production (VOLUME) and Growth Rate (%), (2017-2025)
- 2.3. GLOBAL EDARAVONE MARKET CAPACITY AND GROWTH RATE, 2017-2025
- 2.3.1. Global Edaravone Capacity (VOLUME) and Growth Rate (%), (2017-2025)
- 2.4. GLOBAL EDARAVONE MARKET REVENUE AND GROWTH RATE, 2017-2025
- 2.4.1. Global Edaravone Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
- 2.5. GLOBAL EDARAVONE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 2.5.1. Global Edaravone Consumption (VOLUME) and Growth Rate (%), (2017-2025)
- 2.6. GLOBAL EDARAVONE MARKET PRICE TREND, 2017-2025
- 2.6.1. Global Edaravone Market Price Trend and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL EDARAVONE MARKET BY END-USERS, 2017-2025
- 3.1. HOSPITALS
- 3.2. CLINICS
- 3.3. OTHERS
- 3.4. GLOBAL EDARAVONE MARKET REVENUE BY END-USERS, 2017-2025
- 3.4.1. Global Edaravone Market Revenue (Million USD) and Share (%) By End-users, 2017-2025
- 3.4.2. Hospitals Market Revenue and Growth Rate, 2017-2025
- 3.4.3. Clinics Market Revenue and Growth Rate, 2017-2025
- 3.4.4. Others Market Revenue and Growth Rate, 2017-2025
- 3.5. GLOBAL EDARAVONE MARKET CONSUMPTION BY END-USERS, 2017-2025
- 3.5.1. Global Edaravone Market Consumption (Volume) and share (%) By End-users, 2017-2025
- 3.5.2. Hospitals Market Consumption and Growth Rate, 2017-2025
- 3.5.3. Clinics Market Consumption and Growth Rate, 2017-2025
- 3.5.4. Others Market Consumption and Growth Rate, 2017-2025
CHAPTER 4. GLOBAL EDARAVONE MARKET BY REGION, 2017-2025
- 4.1. NORTH AMERICA
- 4.1.1. U.S.
- 4.1.2. Canada
- 4.1.3. Mexico
- 4.2. EUROPE
- 4.2.1. U.K.
- 4.2.2. France
- 4.2.3. Germany
- 4.2.4. Italy
- 4.2.5. Spain
- 4.2.6. Rest of Europe
- 4.3. ASIA PACIFIC
- 4.3.1. China
- 4.3.2. Japan
- 4.3.3. India
- 4.3.4. Korea
- 4.3.5. Rest of APAC
- 4.4. SOUTH AMERICA
- 4.4.1. Brazil
- 4.4.2. Rest of South America
- 4.5. REST OF THE WORLD
- 4.5.1. Middle East
- 4.5.2. Africa
- 4.6. GLOBAL EDARAVONE MARKET REVENUE BY REGION, 2017-2025
- 4.6.1. Global Edaravone Market Revenue (Million USD) and Share (%) By Region, 2017-2025
- 4.6.2. North America Market Revenue and Growth Rate, 2017-2025
- 4.6.3. Europe Market Revenue and Growth Rate, 2017-2025
- 4.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
- 4.6.5. South America Market Revenue and Growth Rate, 2017-2025
- 4.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 5. GLOBAL EDARAVONE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
- 5.1. GLOBAL EDARAVONE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
- 5.1.1. Global Edaravone Market Production (Volume) and Share (%) By Region, 2017-2025
- 5.1.2. Global Edaravone Market Consumption (Volume) and Share (%) By Region, 2017-2025
- 5.1.3. North America Market Production and Consumption, 2017-2025
- 5.1.4. Europe Market Production and Consumption, 2017-2025
- 5.1.5. Asia Pacific Market Production and Consumption, 2017-2025
- 5.1.6. South America Market Production and Consumption, 2017-2025
- 5.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 6. MARKET DETERMINANTS
- 6.1. MARKET DRIVERS
- 6.2. MARKET RESTRAINTS
- 6.3. MARKET OPPORTUNITIES
- 6.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 7. GLOBAL EDARAVONE MARKET COMPETITION BY MANUFACTURERS
- 7.1. GLOBAL EDARAVONE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
- 7.1.1. Global Edaravone Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
- 7.2. GLOBAL EDARAVONE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
- 7.2.1. Global Edaravone Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
- 7.3. EDARAVONE MARKET COMPETITIVE SITUATION AND TRENDS
- 7.3.1. Edaravone Market Share (%) of Top 3 Manufacturers
- 7.3.2. Edaravone Market Share (%) of Top 5 Manufacturers
CHAPTER 8. GLOBAL EDARAVONE MANUFACTURERS ANALYSIS
- 8.1. MITSUBISHI TANABE PHARMA
- 8.1.1. Business Overview
- 8.1.2. Company Basic Information
- 8.1.3. Edaravone Product Details
- 8.1.4. Mitsubishi Tanabe Pharma Edaravone Production, Revenue and Gross Margin
- 8.2. UNICHEM LABORATORIES LTD
- 8.2.1. Business Overview
- 8.2.2. Company Basic Information
- 8.2.3. Edaravone Product Details
- 8.2.4. Unichem Laboratories Ltd Edaravone Production, Revenue and Gross Margin
- 8.3. TAJ PHARMACEUTICALS LTD.
- 8.3.1. Business Overview
- 8.3.2. Company Basic Information
- 8.3.3. Edaravone Product Details
- 8.3.4. Taj Pharmaceuticals Ltd. Edaravone Production, Revenue and Gross Margin
- 8.4. SIMCERE
- 8.4.1. Business Overview
- 8.4.2. Company Basic Information
- 8.4.3. Edaravone Product Details
- 8.4.4. Simcere Edaravone Production, Revenue and Gross Margin
- 8.5. PIRAMAL HEALTHCARE
- 8.5.1. Business Overview
- 8.5.2. Company Basic Information
- 8.5.3. Edaravone Product Details
- 8.5.4. Piramal Healthcare Edaravone Production, Revenue and Gross Margin
- 8.6. UCB INDIA LTD
- 8.6.1. Business Overview
- 8.6.2. Company Basic Information
- 8.6.3. Edaravone Product Details
- 8.6.4. UCB India Ltd Edaravone Production, Revenue and Gross Margin
- 8.7. SUN PHARMACEUTICAL INDUSTRIES LTD.
- 8.7.1. Business Overview
- 8.7.2. Company Basic Information
- 8.7.3. Edaravone Product Details
- 8.7.4. Sun Pharmaceutical Industries Ltd. Edaravone Production, Revenue and Gross Margin
CHAPTER 9. EDARAVONE MARKET VALUE CHAIN ANALYSIS
- 9.1. EDARAVONE INDUSTRIAL CHAIN ANALYSIS
- 9.2. EDARAVONE KEY RAW MATERIALS ANALYSIS
- 9.2.1. Key Raw Materials
- 9.2.2. Price Trend of Key Raw Materials
- 9.2.3. Key Suppliers of Raw Materials
- 9.3. MARKETING CHANNEL
- 9.3.1. Direct Marketing
- 9.3.2. Indirect Marketing
- 9.3.3. Distributors/Traders
- 9.4. CONSUMER ANALYSIS
- 9.4.1. Consumer 1
- 9.4.2. Consumer 2
- 9.4.3. Consumer 3
“Edaravone Market” 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure.
About Edaravone Market
Edaravone is a neuroprotective agent that is mainly available in the global market under the trademark ‘Radicava’ and ‘Radicut’. Since its advent in the late 1980s, edaravone is gaining popularity among patients recovering from stroke and those who are suffering from amyotrophic lateral sclerosis (ALS). Edaravone set foot in the US market in 2017 after the approval of FDA for its use in the treatment of ALS. Similarly, the drug was approved in Japan in June 2015, followed by South Korea in December 2015 for its application in amyotrophic lateral sclerosis treatment. The global edaravone market is expected to witness an impressive growth during the upcoming years due to the unavailability of an approved alternative drug for treating ALS, except riluzole. However, edaravone has proved to be effective in slowly deteriorating the ALS symptoms, which is not the case with riluzole.
Market Summary:
The Edaravone market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Edaravone Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.
The study on the worldwide Edaravone market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals.
Scope and Segmentation of the Report
The segment analysis is one of the significant sections of this report. Our expert analyst has categorized the market into product type, application/end-user, and geography. All the segments are analyzed based on their market share, growth rate, and growth potential. In the geographical classification, the report highlights the regional markets having high growth potential. This thorough evaluation of the segments would help the players to focus on revenue-generating areas of the Edaravone market.
Based on Type
Product 1
Product 2
Based on Application
Clinics
Hospitals
Others
Regional Analysis
Our analysts are experts in covering all types of geographical markets from developing to mature ones. You can expect a comprehensive research analysis of key regional and country-level markets such as Europe, North America, South America, Asia-Pacific, and the Middle East & Africa. With accurate statistical patterns and regional classification, our domain experts provide you one of the most detailed and easily understandable regional analyses of the Edaravone market.
Competitive Landscape:
The research report also studied the key players operating in the Edaravone market. It has evaluated and explained the research & development stages of these companies, their financial performances, and their expansion plans for the coming years. Moreover, the research report also includes the list of planned initiatives that clearly explain the accomplishments of the companies in the recent past.
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products, etc.):
Mitsubishi Tanabe Pharma
Unichem Laboratories Ltd
Simcere
Taj Pharmaceuticals Ltd.
UCB India Ltd
Piramal Healthcare
Sun Pharmaceutical Industries Ltd.
Research Methodology
The research methodology of the market is based on both primary as well as secondary research data sources. It compels different factors affecting the Edaravone industry such as historical data and market trends, different policies of the government, market environment, market risk factors, market restraints, technological advancements, forthcoming innovations, and obstacles in the industry.
The content of the study subjects includes a total of 8 chapters:
Chapter 1, describe the Edaravone market report’s – executive summary, market definition, and market scope. Moreover, the report helps in picking up the crucial information about the said market.
Chapter 2, defines the Research Methodology including primary research, assumptions & exclusions, and secondary data sources. The report follows the simultaneous top-down and bottom approach to provide you the accurate market sizing.
Chapter 3, explains the report segmentation & scope, key market trends (drivers, restraints, and opportunities), along with Porter’s five forces analysis and market share analysis
Chapter 4: It helps in understanding the key product segments and their future of the Edaravone Market. It provides strategic recommendations in key business segments based on the market estimations.
Chapters 5, and 6 to segment the sales by type and application/end-user, with sales market share and growth rate by type, application/end-user, from 2018 to 2016. Our team of Analysts and experts dedicatedly put their effort to provide you the best possible and accurate segmentation data and analysis.
Chapter 7, describes the regional segmentation based on the country level for the forecast period 2018 – 2026. The research report not only provide the market data of the five geographies but also provide the qualitative as well we qualitative information on country level bifurcation.
Chapter 8, to profile the top manufacturers of Edaravone, with price, sales, revenue and market share of Edaravone in 2016, 2017, and 2018. Players are expected to sign acquisition and collaboration deals to expand their products and services portfolio. Such strategic agreements could help them to improve their client base in other countries and gain a competitive advantage